This is a news story, published by Only Good News Daily, that relates primarily to CPAP news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Only Good News Daily, you can click here:
more news from Only Good News DailyOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
sleep apnea. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest promising new therapeutic option news, new drug treatment news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
obstructive sleep apneaOnly Good News Daily
•76% Informative
Tirzepatide was so successful that many trial participants were able to stop using CPAP machines.
It looks promising that the drug could be the first to effectively treat the condition that affects 936 million people worldwide.
Researchers from the University of California San Diego's School of Medicine tested the use of tirzepetide to improve sleep.
VR Score
75
Informative language
79
Neutral language
52
Article tone
semi-formal
Language
English
Language complexity
67
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
long-living
External references
2
Source diversity
2
Affiliate links
no affiliate links